Visual Impairment News and Research

Latest Visual Impairment News and Research

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Pfizer Oncology today announced that important data from its lung cancer and renal cell carcinoma (RCC) portfolios will be presented at the upcoming European Society for Medical Oncology (ESMO) Congress in Vienna, Austria, September 28 - October 2, 2012.

18 Sep 2012

Gene therapy approach restores ability to smell in mouse model of congenital anosmia

Scientists funded by the National Institutes of Health have restored the ability to smell in a mouse model of a human genetic disorder that causes congenital anosmia-the inability to smell from birth. The approach uses gene therapy to regrow cilia, cell structures that are essential for olfactory function.

3 Sep 2012

Friedreich Ataxia Research Alliance, USF ARC to host ‘Understanding a Cure’ symposium

Scientists, clinicians and patients will gather at the University of South Florida's Center for Advanced Medical Learning and Simulation (CAMLS) in downtown Tampa Sept. 6 to share research insights and energize the search for a cure for Friedreich's ataxia and related disorders.

28 Aug 2012

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical trial to examine a two-month sustained release drug (OTX-TP2) for the treatment of ocular hypertension and glaucoma.

21 Aug 2012

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Genentech, a member of the Roche Group, today announced that Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness

12 Aug 2012

Poorly sighted need help with meds

GPs should check that elderly patients can see well enough to read prescriptions and tell different medications apart, warn UK researchers. They point out that many older patients with visual impairment need help to manage their medications.

3 Aug 2012

$Cataract surgery reduces hip fracture, as well as improving eye sight$

Cataract surgery reduces hip fracture, as well as improving eye sight

Surgery for cataract removal significantly reduces the rate of hip fracture in the year after the procedure compared with no surgery, show study results involving over a million Medicare beneficiaries aged over 65 years.

3 Aug 2012

$Older Medicare patients have reduced risk of hip fracture following cataract surgery$

Older Medicare patients have reduced risk of hip fracture following cataract surgery

Medicare patients 65 years and older who underwent cataract surgery had a lower odds of hip fracture 1 year after the procedure when compared with patients with cataract who did not have cataract surgery, according to a study in the August 1 issue of JAMA.

1 Aug 2012

Visual impairment hampers elderly patients’ self-management

Elderly patients with visual impairment need extra support to help them manage their medications, report UK researchers.

26 Jul 2012

Early-age cataract surgery increases central corneal thickness

When congenital cataract surgery is performed at an early age, central corneal thickness increases, show study results published in the British Journal of Ophthalmology.

25 Jul 2012

Ocular Therapeutix announces results from sustained release OTX-TP1 study on glaucoma

Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period.

24 Jul 2012

Pfizer receives positive opinion from EMA CHMP for crizotinib to treat ALK-positive NSCLC

Pfizer announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that crizotinib be granted conditional marketing authorization in the European Union (EU), for the treatment of adults with previously treated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

21 Jul 2012

Number of blind persons decline in Germany

The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches -rzteblatt International.

21 Jul 2012

Blindsight in monkeys is available in everyday environments

The visual information from eyes is sent into the brain unconsciously even if you are not aware. One of examples of unconscious seeing is a phenomenon of "blindsight" [Subjects have no awareness, but their brains can see] in subjects with visual impairment, caused by the damage of a part of the brain called the visual cortex.

29 Jun 2012

Senior citizens report fewer visual impairment problems than their counterparts

Today's senior citizens are reporting fewer visual impairment problems than their counterparts from a generation ago, according to a new Northwestern Medicine study. Improved techniques for cataract surgery and a reduction in the prevalence of macular degeneration may be the driving forces behind this change, the researchers said.

29 Jun 2012

Cerebral damage risks vision in children born prematurely

Cerebral damage and retinopathy of prematurity are independently associated with the risk for visual impairment in 4-year-old children who were born prematurely, show Danish study results.

22 Jun 2012

Parents not totally responsible for child’s eyesight

Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.

15 Jun 2012

New method enhances adhesion of injected CECs for successful corneal transplantation

Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.

14 Jun 2012

Cerebral damage, ROP may increase risk of visual impairment in extremely preterm children

Cerebral damage and retinopathy of prematurity appear to be independently associated with visual impairment among preschool children who were born extremely premature, according to a report published Online First by Archives of Ophthalmology, a JAMA Network publication.

13 Jun 2012

Sixty-fifth World Health Assembly covers some of the biggest challenges facing public health

The Sixty-fifth World Health Assembly concluded Saturday after adopting 21 resolutions and three decisions on a broad range of health issues. The six days of discussions involved nearly 3000 delegates, including health ministers and senior health officials from amongst the 194 WHO Member States, as well as representatives from civil society and other stakeholders.

28 May 2012

Visual Impairment News and Research

Latest Visual Impairment News and Research

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Gene therapy approach restores ability to smell in mouse model of congenital anosmia

Friedreich Ataxia Research Alliance, USF ARC to host ‘Understanding a Cure’ symposium

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Poorly sighted need help with meds

Cataract surgery reduces hip fracture, as well as improving eye sight

Older Medicare patients have reduced risk of hip fracture following cataract surgery

Visual impairment hampers elderly patients’ self-management

Early-age cataract surgery increases central corneal thickness

Ocular Therapeutix announces results from sustained release OTX-TP1 study on glaucoma

Pfizer receives positive opinion from EMA CHMP for crizotinib to treat ALK-positive NSCLC

Number of blind persons decline in Germany

Blindsight in monkeys is available in everyday environments

Senior citizens report fewer visual impairment problems than their counterparts

Cerebral damage risks vision in children born prematurely

Parents not totally responsible for child’s eyesight

New method enhances adhesion of injected CECs for successful corneal transplantation

Cerebral damage, ROP may increase risk of visual impairment in extremely preterm children

Sixty-fifth World Health Assembly covers some of the biggest challenges facing public health

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Visual Impairment News and Research

Latest Visual Impairment News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in